G1 Therapeutics Inc. (GTHX) NASDAQ

$5.05 -0.22 (-4.17%)

Market Cap: $215.66M

As of 05/20/22 04:00 PM EDT. Market closed.

(GTHX)

G1 Therapeutics Inc. (GTHX) NASDAQ

$5.05 -0.22 (-4.17%)

Market Cap: $215.66M

As of 05/20/22 04:00 PM EDT. Market closed.

G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company's first commercial product, COSELA™ (trilaciclib). G1 has a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including colorectal, ... read more

G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company's first commercial product, COSELA™ (trilaciclib). G1 has a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including colorectal, breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Mark Velleca
Full Time Employees
122
CEO Compensation (Base)
$515,000
CEO Compensation (Total)
$1.91M
URL
Address
700 Park Offices Drive, Suite 200, North Carolina, Research Triangle Park, 27709.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Mark Velleca
Full Time Employees
122
CEO Compensation (Base)
$515,000
CEO Compensation (Total)
$1.91M
Address
700 Park Offices Drive, Suite 200, North Carolina, Research Triangle Park, 27709.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$5.30
Previous Close
$5.27
Days Range
$4.73 - $5.34
52 week range
$4.25 - $24.12
Volume
1,143,082
Avg. Volume (30 days)
1,054,322
Market Cap
$215.66M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
42,705,532
Open
$5.30
Previous Close
$5.27
Days Range
$4.73 - $5.34
52 week range
$4.25 - $24.12
Volume
1,143,082
Avg. Volume (30 days)
1,054,322
Market Cap
$215.66M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
42,705,532

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR G1 THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Velleca Mark A. Director Feb 07, 2022 Option Exercise $0.39 15,000 5,850 116,000 Feb 08, 2022, 04:05 PM
Moses Jennifer K. CFO Feb 01, 2022 Option Exercise $4.11 2,333 9,579 37,888 Feb 02, 2022, 05:20 PM
Malik Rajesh Chief Medical Officer Feb 01, 2022 Option Exercise $0.30 10,000 3,000 73,855 Feb 02, 2022, 05:20 PM
Hanson James S. General Counsel Jan 05, 2022 Sale $10.61 1,445 15,334 25,555 Jan 05, 2022, 08:48 PM
MURDOCK TERRY L Chief Operating Officer Jan 05, 2022 Sale $10.61 1,445 15,334 21,555 Jan 05, 2022, 08:25 PM
Moses Jennifer K. CFO Jan 05, 2022 Sale $10.61 1,445 15,334 35,555 Jan 05, 2022, 08:25 PM
Malik Rajesh Chief Medical Officer Jan 05, 2022 Sale $10.61 1,445 15,334 63,855 Jan 05, 2022, 08:24 PM
Avagliano Mark Chief Business Officer Jan 05, 2022 Sale $10.61 1,445 15,334 21,555 Jan 05, 2022, 08:24 PM
Bailey John E. (Jack) Jr. President and CEO Jan 03, 2022 Sale $10.41 34,125 355,262 233,208 Jan 05, 2022, 08:24 PM
Velleca Mark A. Director Nov 09, 2021 Option Exercise $0.39 40,000 15,600 101,000 Nov 10, 2021, 04:05 PM
Velleca Mark A. Director Jul 13, 2021 Option Exercise $0.39 10,000 3,900 71,000 Jul 15, 2021, 04:01 PM
Velleca Mark A. Director Jul 15, 2021 Option Exercise $0.39 10,000 3,900 71,000 Jul 15, 2021, 04:01 PM
Velleca Mark A. Director Jul 14, 2021 Option Exercise $0.39 10,000 3,900 71,000 Jul 15, 2021, 04:01 PM
Velleca Mark A. Director Jul 15, 2021 Sale $18.49 10,000 184,898 61,000 Jul 15, 2021, 04:01 PM
Velleca Mark A. Director Jul 14, 2021 Sale $19.08 10,000 190,824 61,000 Jul 15, 2021, 04:01 PM
Velleca Mark A. Director Jul 13, 2021 Sale $19.45 10,000 194,536 61,000 Jul 15, 2021, 04:01 PM
RUDNICK SETH Director Jun 29, 2021 Option Exercise $0.37 10,000 3,717 14,389 Jun 30, 2021, 04:05 PM
RUDNICK SETH Director Jun 29, 2021 Sale $22.35 10,000 223,477 4,389 Jun 30, 2021, 04:05 PM
Velleca Mark A. Director Jun 16, 2021 Option Exercise $0.39 10,000 3,900 71,000 Jun 17, 2021, 04:05 PM
Velleca Mark A. Director Jun 15, 2021 Option Exercise $0.39 10,000 3,900 71,000 Jun 17, 2021, 04:05 PM
Velleca Mark A. Director Jun 17, 2021 Option Exercise $0.39 10,000 3,900 71,000 Jun 17, 2021, 04:05 PM
Velleca Mark A. Director Jun 15, 2021 Sale $22.39 10,000 223,909 61,000 Jun 17, 2021, 04:05 PM
Velleca Mark A. Director Jun 17, 2021 Sale $21.77 10,000 217,728 61,000 Jun 17, 2021, 04:05 PM
Velleca Mark A. Director Jun 16, 2021 Sale $21.74 10,000 217,384 61,000 Jun 17, 2021, 04:05 PM
Velleca Mark A. Director May 25, 2021 Option Exercise $0.39 20,000 7,800 61,000 May 25, 2021, 06:29 PM
Malik Rajesh Chief Medical Officer Apr 22, 2021 Option Exercise $0.39 15,000 5,850 58,300 Apr 23, 2021, 04:39 PM
Malik Rajesh Chief Medical Officer Apr 22, 2021 Sale $22.07 15,000 331,099 43,300 Apr 23, 2021, 04:39 PM
Malik Rajesh Chief Medical Officer Mar 23, 2021 Option Exercise $0.39 15,000 5,850 58,300 Mar 24, 2021, 04:47 PM
Malik Rajesh Chief Medical Officer Mar 23, 2021 Sale $21.94 15,000 329,059 43,300 Mar 24, 2021, 04:47 PM
Malik Rajesh Chief Medical Officer Mar 02, 2021 Option Exercise $1.55 15,000 23,219 58,300 Mar 04, 2021, 05:10 PM
Malik Rajesh Chief Medical Officer Mar 02, 2021 Sale $22.95 15,000 344,192 43,300 Mar 04, 2021, 05:10 PM
Moses Jennifer K. CFO Mar 03, 2021 Option Exercise $3.72 3,000 11,160 25,000 Mar 04, 2021, 04:54 PM
Velleca Mark A. Director Feb 16, 2021 Option Exercise $3.72 11,040 41,069 52,040 Feb 18, 2021, 05:49 PM
Velleca Mark A. Director Feb 18, 2021 Option Exercise $3.72 10,000 37,200 51,000 Feb 18, 2021, 05:49 PM
Velleca Mark A. Director Feb 17, 2021 Option Exercise $3.72 10,000 37,200 51,000 Feb 18, 2021, 05:49 PM
Velleca Mark A. Director Feb 18, 2021 Sale $26.02 10,000 260,152 41,000 Feb 18, 2021, 05:49 PM
Velleca Mark A. Director Feb 17, 2021 Sale $27.64 10,000 276,433 41,600 Feb 18, 2021, 05:49 PM
Velleca Mark A. Director Feb 16, 2021 Sale $35.20 11,040 388,653 43,723 Feb 18, 2021, 05:49 PM
Malik Rajesh Chief Medical Officer Jan 27, 2021 Option Exercise $0.39 3,100 1,209 43,300 Jan 29, 2021, 04:07 PM
Malik Rajesh Chief Medical Officer Jan 22, 2021 Option Exercise $4.17 15,000 62,550 55,200 Jan 22, 2021, 06:47 PM
Malik Rajesh Chief Medical Officer Jan 22, 2021 Sale $20.64 15,000 309,591 40,200 Jan 22, 2021, 06:47 PM
Velleca Mark A. Director Jan 21, 2021 Option Exercise $3.72 10,000 37,200 51,000 Jan 21, 2021, 05:31 PM
Velleca Mark A. Director Jan 20, 2021 Option Exercise $2.77 14,000 38,760 47,000 Jan 21, 2021, 05:31 PM
Velleca Mark A. Director Jan 19, 2021 Option Exercise $3.72 10,000 37,200 47,000 Jan 21, 2021, 05:31 PM
Velleca Mark A. Director Jan 20, 2021 Sale $21.51 10,000 215,107 37,000 Jan 21, 2021, 05:31 PM
Velleca Mark A. Director Jan 19, 2021 Sale $20.88 10,000 208,781 37,000 Jan 21, 2021, 05:31 PM
Velleca Mark A. Director Jan 21, 2021 Sale $20.64 10,000 206,400 41,000 Jan 21, 2021, 05:31 PM
RUDNICK SETH Director Dec 24, 2020 Sale $20.10 924 18,572 5,266 Dec 29, 2020, 04:50 PM
RUDNICK SETH Director Dec 23, 2020 Sale $20.18 13,118 264,757 6,190 Dec 23, 2020, 06:54 PM
RUDNICK SETH Director Dec 22, 2020 Sale $20.33 18,974 385,702 19,308 Dec 23, 2020, 06:54 PM
Velleca Mark A. President and CEO Dec 16, 2020 Option Exercise $3.72 10,000 37,200 47,000 Dec 17, 2020, 06:01 PM
Velleca Mark A. President and CEO Dec 15, 2020 Option Exercise $3.72 10,000 37,200 47,000 Dec 17, 2020, 06:01 PM
Velleca Mark A. President and CEO Dec 17, 2020 Option Exercise $3.72 10,000 37,200 47,000 Dec 17, 2020, 06:01 PM
Velleca Mark A. President and CEO Dec 15, 2020 Sale $19.43 10,000 194,297 37,000 Dec 17, 2020, 06:01 PM
Velleca Mark A. President and CEO Dec 17, 2020 Sale $19.97 10,000 199,668 37,000 Dec 17, 2020, 06:01 PM
Velleca Mark A. President and CEO Dec 16, 2020 Sale $19.20 10,000 192,021 37,000 Dec 17, 2020, 06:01 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Dec 10, 2020 Option Exercise $4.17 9,000 37,530 38,200 Dec 11, 2020, 04:50 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Dec 10, 2020 Sale $20.06 9,000 180,550 29,200 Dec 11, 2020, 04:50 PM
RUDNICK SETH Director Dec 10, 2020 Sale $20.00 546 10,921 38,282 Dec 10, 2020, 05:30 PM
RUDNICK SETH Director Dec 09, 2020 Sale $20.32 5,773 117,284 38,828 Dec 10, 2020, 05:30 PM
RUDNICK SETH Director Dec 08, 2020 Sale $20.19 13,161 265,694 44,601 Dec 10, 2020, 05:30 PM
RUDNICK SETH Director Dec 01, 2020 Sale $20.09 520 10,449 57,762 Dec 03, 2020, 04:20 PM
MUIR GLENN P Director Nov 18, 2020 Buy $13.50 50,000 675,000 170,969 Nov 19, 2020, 04:54 PM
Bailey John E. (Jack) Jr. Director Nov 11, 2020 Buy $12.83 4,000 51,320 8,000 Nov 13, 2020, 04:33 PM
Bailey John E. (Jack) Jr. Director Nov 10, 2020 Buy $12.76 4,000 51,055 4,000 Nov 13, 2020, 04:33 PM
Hanson James S. General Counsel Sep 04, 2020 Buy $14.95 1,000 14,950 4,000 Sep 08, 2020, 08:38 PM
Moses Jennifer K. CFO Mar 13, 2020 Option Exercise $3.72 2,000 7,440 11,000 Mar 16, 2020, 07:00 AM
Malik Rajesh Ch. Medical Officer & SVP R&D Mar 13, 2020 Option Exercise $0.39 2,500 975 29,200 Mar 16, 2020, 07:00 AM
Velleca Mark A. President and CEO Mar 13, 2020 Option Exercise $0.39 3,000 1,170 37,000 Mar 16, 2020, 07:00 AM
Velleca Mark A. President and CEO Jan 23, 2020 Option Exercise $0.39 6,000 2,340 34,000 Jan 24, 2020, 04:59 PM
Moses Jennifer K. CFO Jan 23, 2020 Option Exercise $3.72 1,000 3,720 9,000 Jan 24, 2020, 04:58 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Jan 23, 2020 Option Exercise $0.39 5,000 1,950 26,700 Jan 24, 2020, 04:58 PM
Moses Jennifer K. CFO Jul 18, 2019 Option Exercise $3.72 2,000 7,440 8,000 Jul 19, 2019, 09:58 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Jan 28, 2019 Option Exercise $0.39 7,000 2,730 21,700 Jan 28, 2019, 09:10 PM
Moses Jennifer K. VP of Finance Jan 17, 2019 Option Exercise $3.72 2,000 7,440 6,000 Jan 17, 2019, 05:52 PM
Velleca Mark A. President and CEO Jan 17, 2019 Option Exercise $0.39 9,000 3,510 28,000 Jan 17, 2019, 05:52 PM
Strum Jay Chief Scientific Officer Jan 02, 2019 Option Exercise $0.35 79,818 27,575 129,237 Jan 02, 2019, 05:46 PM
Hanson James S. General Counsel Dec 26, 2018 Buy $18.25 1,000 18,250 3,000 Dec 27, 2018, 04:59 PM
Schwalm Cynthia Director Dec 26, 2018 Buy $18.45 1,420 26,196 1,500 Dec 27, 2018, 04:59 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Dec 17, 2018 Option Exercise $4.17 3,776 15,746 18,476 Dec 17, 2018, 04:27 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Dec 17, 2018 Sale $30.00 3,776 113,280 14,700 Dec 17, 2018, 04:27 PM
Hanson James S. General Counsel Dec 10, 2018 Buy $32.51 1,000 32,508 2,000 Dec 11, 2018, 04:08 PM
DEMAREE JOHN Chief Commercial Officer Dec 10, 2018 Buy $33.15 1,000 33,151 5,250 Dec 11, 2018, 04:08 PM
Moses Jennifer K. VP of Finance & Admin Dec 06, 2018 Option Exercise $0.39 750 292 2,750 Dec 07, 2018, 04:07 PM
Moses Jennifer K. VP of Finance & Admin Dec 07, 2018 Option Exercise $3.72 2,000 7,440 4,000 Dec 07, 2018, 04:07 PM
Moses Jennifer K. VP of Finance & Admin Dec 06, 2018 Sale $34.00 750 25,500 2,000 Dec 07, 2018, 04:07 PM
RUDNICK SETH Director Dec 04, 2018 Option Exercise $0.39 10,000 3,900 10,000 Dec 04, 2018, 06:10 PM
RUDNICK SETH Director Dec 04, 2018 Sale $39.31 10,000 393,146 116 Dec 04, 2018, 06:10 PM
MURDOCK TERRY L SVP of Development Operations Dec 03, 2018 Option Exercise $13.51 3,523 47,596 3,523 Dec 03, 2018, 06:25 PM
MURDOCK TERRY L SVP of Development Operations Dec 03, 2018 Sale $38.54 3,523 135,779 0 Dec 03, 2018, 06:25 PM
PHILLIPS BARCLAY A SVP & Chief Financial Officer Nov 15, 2018 Option Exercise $19.46 5,000 97,300 5,000 Nov 16, 2018, 07:16 PM
PHILLIPS BARCLAY A SVP & Chief Financial Officer Nov 15, 2018 Sale $39.92 5,000 199,591 0 Nov 16, 2018, 07:16 PM
Velleca Mark A. President and CEO Nov 15, 2018 Option Exercise $3.72 5,000 18,600 24,000 Nov 16, 2018, 05:17 PM
Velleca Mark A. President and CEO Nov 15, 2018 Sale $39.84 5,000 199,211 19,015 Nov 16, 2018, 05:17 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Nov 15, 2018 Option Exercise $4.17 3,776 15,746 18,476 Nov 16, 2018, 05:17 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Nov 15, 2018 Sale $39.75 3,776 150,105 14,947 Nov 16, 2018, 05:17 PM
RUDNICK SETH Director Nov 05, 2018 Option Exercise $0.39 10,000 3,900 10,000 Nov 07, 2018, 06:18 PM
RUDNICK SETH Director Nov 05, 2018 Sale $41.53 10,000 415,347 0 Nov 07, 2018, 06:18 PM
MURDOCK TERRY L SVP of Development Operations Nov 05, 2018 Option Exercise $13.51 3,519 47,542 3,519 Nov 07, 2018, 06:18 PM
MURDOCK TERRY L SVP of Development Operations Nov 05, 2018 Sale $41.53 3,519 146,129 0 Nov 07, 2018, 06:18 PM
Moses Jennifer K. VP of Finance & Admin Nov 05, 2018 Option Exercise $0.39 750 292 2,750 Nov 07, 2018, 06:15 PM
Moses Jennifer K. VP of Finance & Admin Nov 05, 2018 Sale $41.38 750 31,035 2,000 Nov 07, 2018, 06:15 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Oct 15, 2018 Option Exercise $1.81 10,076 18,203 14,700 Oct 15, 2018, 05:57 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Oct 15, 2018 Sale $41.71 3,776 157,497 11,233 Oct 15, 2018, 05:57 PM
Velleca Mark A. President and CEO Oct 11, 2018 Option Exercise $0.39 10,000 3,900 19,000 Oct 15, 2018, 05:54 PM
Velleca Mark A. President and CEO Oct 15, 2018 Option Exercise $3.72 5,000 18,600 24,000 Oct 15, 2018, 05:54 PM
Velleca Mark A. President and CEO Oct 15, 2018 Sale $41.53 5,000 207,645 21,837 Oct 15, 2018, 05:54 PM
Moses Jennifer K. VP of Finance & Admin Oct 08, 2018 Option Exercise $0.39 750 292 2,750 Oct 10, 2018, 04:45 PM
Moses Jennifer K. VP of Finance & Admin Oct 08, 2018 Sale $44.52 750 33,390 2,000 Oct 10, 2018, 04:45 PM
Strum Jay Chief Scientific Officer Oct 04, 2018 Option Exercise $0.30 850 255 49,419 Oct 05, 2018, 06:04 PM
RUDNICK SETH Director Oct 04, 2018 Option Exercise $0.39 10,000 3,900 10,000 Oct 05, 2018, 06:02 PM
RUDNICK SETH Director Oct 04, 2018 Sale $49.72 10,000 497,210 1,980 Oct 05, 2018, 06:02 PM
MURDOCK TERRY L SVP of Development Operations Oct 03, 2018 Option Exercise $13.51 3,519 47,542 3,519 Oct 05, 2018, 06:02 PM
MURDOCK TERRY L SVP of Development Operations Oct 03, 2018 Sale $49.18 3,519 173,064 0 Oct 05, 2018, 06:02 PM
Velleca Mark A. President and CEO Sep 17, 2018 Option Exercise $3.72 5,000 18,600 14,000 Sep 19, 2018, 07:08 PM
Velleca Mark A. President and CEO Sep 17, 2018 Sale $66.31 5,000 331,549 11,165 Sep 19, 2018, 07:08 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Sep 17, 2018 Option Exercise $4.17 3,776 15,746 12,176 Sep 19, 2018, 07:07 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Sep 17, 2018 Sale $66.08 3,776 249,502 9,184 Sep 19, 2018, 07:07 PM
Moses Jennifer K. VP of Finance & Admin Sep 05, 2018 Option Exercise $2.81 2,750 7,733 2,000 Sep 06, 2018, 04:07 PM
Moses Jennifer K. VP of Finance & Admin Sep 05, 2018 Sale $59.60 750 44,700 0 Sep 06, 2018, 04:07 PM
RUDNICK SETH Director Sep 04, 2018 Option Exercise $0.39 10,000 3,900 10,000 Sep 06, 2018, 04:07 PM
RUDNICK SETH Director Sep 04, 2018 Sale $59.95 10,000 599,483 500 Sep 06, 2018, 04:07 PM
MURDOCK TERRY L SVP of Development Operations Sep 04, 2018 Option Exercise $13.51 3,519 47,542 3,519 Sep 06, 2018, 04:06 PM
MURDOCK TERRY L SVP of Development Operations Sep 04, 2018 Sale $59.98 3,519 211,065 0 Sep 06, 2018, 04:06 PM
Strum Jay Chief Scientific Officer Aug 30, 2018 Sale $59.98 5,000 299,876 53,069 Aug 31, 2018, 04:20 PM
Strum Jay Chief Scientific Officer Aug 29, 2018 Sale $59.22 5,000 296,095 57,969 Aug 31, 2018, 04:20 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Aug 15, 2018 Option Exercise $4.17 3,776 15,746 12,176 Aug 17, 2018, 03:00 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Aug 15, 2018 Sale $55.89 3,776 211,023 10,100 Aug 17, 2018, 03:00 PM
Velleca Mark A. President and CEO Aug 15, 2018 Option Exercise $3.72 5,000 18,600 14,000 Aug 17, 2018, 02:59 PM
Velleca Mark A. President and CEO Aug 15, 2018 Sale $55.88 5,000 279,378 11,301 Aug 17, 2018, 02:59 PM
RUDNICK SETH Director Aug 06, 2018 Option Exercise $0.39 10,000 3,900 10,000 Aug 06, 2018, 06:19 PM
RUDNICK SETH Director Aug 06, 2018 Sale $50.69 10,000 506,901 0 Aug 06, 2018, 06:19 PM
Moses Jennifer K. VP of Finance & Admin Aug 06, 2018 Option Exercise $0.39 750 292 750 Aug 06, 2018, 06:18 PM
Moses Jennifer K. VP of Finance & Admin Aug 06, 2018 Sale $50.79 750 38,093 0 Aug 06, 2018, 06:18 PM
MURDOCK TERRY L SVP of Development Operations Aug 03, 2018 Option Exercise $13.51 3,519 47,542 3,519 Aug 06, 2018, 06:17 PM
MURDOCK TERRY L SVP of Development Operations Aug 03, 2018 Sale $50.60 3,519 178,061 0 Aug 06, 2018, 06:17 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Jul 16, 2018 Option Exercise $4.17 3,776 15,746 12,176 Jul 17, 2018, 04:01 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Jul 16, 2018 Sale $42.17 3,776 159,248 9,662 Jul 17, 2018, 04:01 PM
Velleca Mark A. President and CEO Jul 16, 2018 Option Exercise $3.72 5,000 18,600 14,000 Jul 17, 2018, 04:01 PM
Velleca Mark A. President and CEO Jul 16, 2018 Sale $42.06 5,000 210,313 10,200 Jul 17, 2018, 04:01 PM
Moses Jennifer K. VP of Finance & Admin Jul 05, 2018 Option Exercise $0.39 750 292 750 Jul 05, 2018, 03:21 PM
Moses Jennifer K. VP of Finance & Admin Jul 05, 2018 Sale $45.66 750 34,245 0 Jul 05, 2018, 03:21 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Jun 15, 2018 Option Exercise $4.17 3,776 15,746 12,176 Jun 18, 2018, 10:19 AM
Malik Rajesh Ch. Medical Officer & SVP R&D Jun 15, 2018 Sale $44.31 3,776 167,326 8,400 Jun 18, 2018, 10:19 AM
Malik Rajesh Ch. Medical Officer & SVP R&D Jun 08, 2018 Option Exercise $0.39 4,200 1,638 8,400 Jun 11, 2018, 10:51 AM
Moses Jennifer K. VP of Finance & Admin Jun 05, 2018 Option Exercise $0.39 750 292 750 Jun 05, 2018, 02:23 PM
Moses Jennifer K. VP of Finance & Admin Jun 05, 2018 Sale $38.77 750 29,078 0 Jun 05, 2018, 02:23 PM
Thorp Clay 10% Owner May 30, 2018 Sale $48.00 800,000 38,400,000 3,279,421 Jun 01, 2018, 06:22 PM
Velleca Mark A. President and CEO May 31, 2018 Option Exercise $0.39 10,000 3,900 10,000 May 31, 2018, 04:22 PM
Thorp Clay 10% Owner May 23, 2018 Sale $50.50 500 25,250 4,037,737 May 23, 2018, 08:46 PM
Thorp Clay 10% Owner May 22, 2018 Sale $50.85 5,900 300,016 4,038,519 May 23, 2018, 08:46 PM
Thorp Clay 10% Owner May 21, 2018 Sale $51.17 31,100 1,591,411 4,046,206 May 23, 2018, 08:46 PM
Velleca Mark A. President and CEO May 15, 2018 Option Exercise $3.72 7,500 27,900 7,500 May 16, 2018, 01:37 PM
Velleca Mark A. President and CEO May 15, 2018 Sale $46.28 7,500 347,064 1,700 May 16, 2018, 01:37 PM
Malik Rajesh Ch. Medical Officer & SVP R&D May 15, 2018 Option Exercise $4.17 3,776 15,746 7,976 May 16, 2018, 01:37 PM
Malik Rajesh Ch. Medical Officer & SVP R&D May 15, 2018 Sale $46.30 3,776 174,821 4,300 May 16, 2018, 01:37 PM
Moses Jennifer K. VP of Finance & Admin May 07, 2018 Option Exercise $0.39 750 292 750 May 07, 2018, 03:04 PM
Moses Jennifer K. VP of Finance & Admin May 07, 2018 Sale $45.00 750 33,750 0 May 07, 2018, 03:04 PM
Velleca Mark A. President and CEO Apr 16, 2018 Option Exercise $3.72 7,500 27,900 7,500 Apr 17, 2018, 12:20 PM
Velleca Mark A. President and CEO Apr 16, 2018 Sale $36.00 7,500 269,971 500 Apr 17, 2018, 12:20 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Apr 16, 2018 Option Exercise $4.17 3,776 15,746 7,976 Apr 17, 2018, 12:20 PM
Malik Rajesh Ch. Medical Officer & SVP R&D Apr 16, 2018 Sale $36.05 3,776 136,135 4,700 Apr 17, 2018, 12:20 PM
Moses Jennifer K. VP of Finance & Admin Apr 05, 2018 Option Exercise $0.39 750 292 750 Apr 05, 2018, 04:04 PM
Moses Jennifer K. VP of Finance & Admin Apr 05, 2018 Sale $37.47 750 28,103 0 Apr 05, 2018, 04:04 PM
Velleca Mark A. President and CEO Mar 15, 2018 Option Exercise $3.72 7,500 27,900 7,500 Mar 16, 2018, 10:09 AM
Velleca Mark A. President and CEO Mar 15, 2018 Sale $38.20 7,500 286,466 0 Mar 16, 2018, 10:09 AM
Malik Rajesh Ch. Medical Officer & SVP R&D Mar 15, 2018 Option Exercise $0.89 3,776 3,348 7,976 Mar 16, 2018, 10:09 AM
Malik Rajesh Ch. Medical Officer & SVP R&D Mar 15, 2018 Sale $38.18 3,776 144,151 4,200 Mar 16, 2018, 10:09 AM
Malik Rajesh Ch. Medical Officer & SVP R&D Mar 08, 2018 Option Exercise $0.39 4,200 1,638 4,200 Mar 09, 2018, 02:36 PM
Moses Jennifer K. VP of Finance & Admin Mar 05, 2018 Option Exercise $0.39 750 292 750 Mar 06, 2018, 04:01 PM
Moses Jennifer K. VP of Finance & Admin Mar 05, 2018 Sale $26.55 750 19,912 0 Mar 06, 2018, 04:01 PM
Velleca Mark A. President and CEO Feb 15, 2018 Option Exercise $3.72 7,500 27,900 7,500 Feb 16, 2018, 11:54 AM
Velleca Mark A. President and CEO Feb 15, 2018 Sale $20.00 7,500 150,015 0 Feb 16, 2018, 11:54 AM
Malik Rajesh Ch. Medical Officer & SVP R&D Feb 15, 2018 Option Exercise $0.32 3,776 1,213 3,776 Feb 16, 2018, 11:54 AM
Malik Rajesh Ch. Medical Officer & SVP R&D Feb 15, 2018 Sale $20.00 3,776 75,520 0 Feb 16, 2018, 11:54 AM
Moses Jennifer K. VP of Finance & Admin Feb 05, 2018 Option Exercise $0.39 750 292 750 Feb 06, 2018, 11:00 AM
Moses Jennifer K. VP of Finance & Admin Feb 05, 2018 Sale $22.99 750 17,242 0 Feb 06, 2018, 11:00 AM
Velleca Mark A. President and CEO Jan 16, 2018 Option Exercise $3.72 7,500 27,900 7,500 Jan 17, 2018, 09:48 AM
Velleca Mark A. President and CEO Jan 16, 2018 Sale $22.99 7,500 172,395 0 Jan 17, 2018, 09:48 AM
Malik Rajesh Ch. Medical Officer & SVP R&D Jan 16, 2018 Option Exercise $0.30 3,776 1,133 3,776 Jan 17, 2018, 09:47 AM
Malik Rajesh Ch. Medical Officer & SVP R&D Jan 16, 2018 Sale $22.96 3,776 86,693 0 Jan 17, 2018, 09:47 AM
Moses Jennifer K. VP of Finance & Admin Jan 05, 2018 Option Exercise $0.39 750 292 750 Jan 08, 2018, 09:42 AM
Moses Jennifer K. VP of Finance & Admin Jan 05, 2018 Sale $19.96 750 14,970 0 Jan 08, 2018, 09:42 AM
Velleca Mark A. President and CEO Dec 18, 2017 Option Exercise $3.72 7,500 27,900 7,500 Dec 20, 2017, 08:48 AM
Velleca Mark A. President and CEO Dec 18, 2017 Sale $20.01 7,500 150,106 0 Dec 20, 2017, 08:48 AM
MedImmune Ventures, Inc. 10% Owner Dec 15, 2017 Sale $19.75 200,000 3,950,000 2,950,630 Dec 18, 2017, 05:48 PM
MedImmune Ventures, Inc. 10% Owner May 17, 2017 Buy $15.00 75,000 1,125,000 3,409,536 Dec 13, 2017, 11:46 AM
MedImmune Ventures, Inc. 10% Owner Dec 01, 2017 Sale $19.75 133,906 2,644,644 3,150,630 Dec 05, 2017, 09:17 AM
MedImmune Ventures, Inc. 10% Owner Nov 20, 2017 Sale $20.01 200,000 4,002,000 3,284,536 Nov 22, 2017, 10:13 AM
ESHELMAN FREDRIC N Director Nov 13, 2017 Buy $19.73 250,000 4,932,500 250,000 Nov 15, 2017, 05:12 PM
Eshelman Ventures, LLC 10% Owner May 22, 2017 Buy $15.00 300,000 4,500,000 3,439,151 May 24, 2017, 08:29 PM
Thorp Clay 10% Owner May 22, 2017 Buy $15.00 133,333 1,999,995 3,861,797 May 24, 2017, 08:18 PM
ESHELMAN FREDRIC N Director May 22, 2017 Buy $15.00 300,000 4,500,000 3,439,151 May 24, 2017, 08:05 PM
MUIR GLENN P Director May 22, 2017 Buy $15.00 20,000 300,000 120,969 May 24, 2017, 07:58 PM
MedImmune Ventures, Inc. 10% Owner May 22, 2017 Buy $15.00 75,000 1,125,000 3,484,536 May 24, 2017, 07:57 PM
RA CAPITAL MANAGEMENT, LLC Fmr 10% Owner See Footnote (2) May 22, 2017 Buy $15.00 400,000 6,000,000 2,684,244 May 24, 2017, 04:34 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Velleca Mark A. Director 02/07/2022 5,850
Moses Jennifer K. CFO 02/01/2022 9,579
Malik Rajesh Chief Medical Officer 02/01/2022 3,000
Hanson James S. General Counsel 01/05/2022 15,334
MURDOCK TERRY L Chief Operating Officer 01/05/2022 15,334
Moses Jennifer K. CFO 01/05/2022 15,334
Malik Rajesh Chief Medical Officer 01/05/2022 15,334
Avagliano Mark Chief Business Officer 01/05/2022 15,334
Bailey John E. (Jack) Jr. President and CEO 01/03/2022 355,262
Velleca Mark A. Director 11/09/2021 15,600
Velleca Mark A. Director 07/13/2021 3,900
Velleca Mark A. Director 07/15/2021 3,900
Velleca Mark A. Director 07/14/2021 3,900
Velleca Mark A. Director 07/15/2021 184,898
Velleca Mark A. Director 07/14/2021 190,824
Velleca Mark A. Director 07/13/2021 194,536
RUDNICK SETH Director 06/29/2021 3,717
RUDNICK SETH Director 06/29/2021 223,477
Velleca Mark A. Director 06/16/2021 3,900
Velleca Mark A. Director 06/15/2021 3,900
Velleca Mark A. Director 06/17/2021 3,900
Velleca Mark A. Director 06/15/2021 223,909
Velleca Mark A. Director 06/17/2021 217,728
Velleca Mark A. Director 06/16/2021 217,384
Velleca Mark A. Director 05/25/2021 7,800
Malik Rajesh Chief Medical Officer 04/22/2021 5,850
Malik Rajesh Chief Medical Officer 04/22/2021 331,099
Malik Rajesh Chief Medical Officer 03/23/2021 5,850
Malik Rajesh Chief Medical Officer 03/23/2021 329,059
Malik Rajesh Chief Medical Officer 03/02/2021 23,219
Malik Rajesh Chief Medical Officer 03/02/2021 344,192
Moses Jennifer K. CFO 03/03/2021 11,160
Velleca Mark A. Director 02/16/2021 41,069
Velleca Mark A. Director 02/18/2021 37,200
Velleca Mark A. Director 02/17/2021 37,200
Velleca Mark A. Director 02/18/2021 260,152
Velleca Mark A. Director 02/17/2021 276,433
Velleca Mark A. Director 02/16/2021 388,653
Malik Rajesh Chief Medical Officer 01/27/2021 1,209
Malik Rajesh Chief Medical Officer 01/22/2021 62,550
Malik Rajesh Chief Medical Officer 01/22/2021 309,591
Velleca Mark A. Director 01/21/2021 37,200
Velleca Mark A. Director 01/20/2021 38,760
Velleca Mark A. Director 01/19/2021 37,200
Velleca Mark A. Director 01/20/2021 215,107
Velleca Mark A. Director 01/19/2021 208,781
Velleca Mark A. Director 01/21/2021 206,400
RUDNICK SETH Director 12/24/2020 18,572
RUDNICK SETH Director 12/23/2020 264,757
RUDNICK SETH Director 12/22/2020 385,702
Velleca Mark A. President and CEO 12/16/2020 37,200
Velleca Mark A. President and CEO 12/15/2020 37,200
Velleca Mark A. President and CEO 12/17/2020 37,200
Velleca Mark A. President and CEO 12/15/2020 194,297
Velleca Mark A. President and CEO 12/17/2020 199,668
Velleca Mark A. President and CEO 12/16/2020 192,021
Malik Rajesh Ch. Medical Officer & SVP R&D 12/10/2020 37,530
Malik Rajesh Ch. Medical Officer & SVP R&D 12/10/2020 180,550
RUDNICK SETH Director 12/10/2020 10,921
RUDNICK SETH Director 12/09/2020 117,284
RUDNICK SETH Director 12/08/2020 265,694
RUDNICK SETH Director 12/01/2020 10,449
MUIR GLENN P Director 11/18/2020 675,000
Bailey John E. (Jack) Jr. Director 11/11/2020 51,320
Bailey John E. (Jack) Jr. Director 11/10/2020 51,055
Hanson James S. General Counsel 09/04/2020 14,950
Moses Jennifer K. CFO 03/13/2020 7,440
Malik Rajesh Ch. Medical Officer & SVP R&D 03/13/2020 975
Velleca Mark A. President and CEO 03/13/2020 1,170
Velleca Mark A. President and CEO 01/23/2020 2,340
Moses Jennifer K. CFO 01/23/2020 3,720
Malik Rajesh Ch. Medical Officer & SVP R&D 01/23/2020 1,950
Moses Jennifer K. CFO 07/18/2019 7,440
Malik Rajesh Ch. Medical Officer & SVP R&D 01/28/2019 2,730
Moses Jennifer K. VP of Finance 01/17/2019 7,440
Velleca Mark A. President and CEO 01/17/2019 3,510
Strum Jay Chief Scientific Officer 01/02/2019 27,575
Hanson James S. General Counsel 12/26/2018 18,250
Schwalm Cynthia Director 12/26/2018 26,196
Malik Rajesh Ch. Medical Officer & SVP R&D 12/17/2018 15,746
Malik Rajesh Ch. Medical Officer & SVP R&D 12/17/2018 113,280
Hanson James S. General Counsel 12/10/2018 32,508
DEMAREE JOHN Chief Commercial Officer 12/10/2018 33,151
Moses Jennifer K. VP of Finance & Admin 12/06/2018 292
Moses Jennifer K. VP of Finance & Admin 12/07/2018 7,440
Moses Jennifer K. VP of Finance & Admin 12/06/2018 25,500
RUDNICK SETH Director 12/04/2018 3,900
RUDNICK SETH Director 12/04/2018 393,146
MURDOCK TERRY L SVP of Development Operations 12/03/2018 47,596
MURDOCK TERRY L SVP of Development Operations 12/03/2018 135,779
PHILLIPS BARCLAY A SVP & Chief Financial Officer 11/15/2018 97,300
PHILLIPS BARCLAY A SVP & Chief Financial Officer 11/15/2018 199,591
Velleca Mark A. President and CEO 11/15/2018 18,600
Velleca Mark A. President and CEO 11/15/2018 199,211
Malik Rajesh Ch. Medical Officer & SVP R&D 11/15/2018 15,746
Malik Rajesh Ch. Medical Officer & SVP R&D 11/15/2018 150,105
RUDNICK SETH Director 11/05/2018 3,900
RUDNICK SETH Director 11/05/2018 415,347
MURDOCK TERRY L SVP of Development Operations 11/05/2018 47,542
MURDOCK TERRY L SVP of Development Operations 11/05/2018 146,129
Moses Jennifer K. VP of Finance & Admin 11/05/2018 292
Moses Jennifer K. VP of Finance & Admin 11/05/2018 31,035
Malik Rajesh Ch. Medical Officer & SVP R&D 10/15/2018 18,203
Malik Rajesh Ch. Medical Officer & SVP R&D 10/15/2018 157,497
Velleca Mark A. President and CEO 10/11/2018 3,900
Velleca Mark A. President and CEO 10/15/2018 18,600
Velleca Mark A. President and CEO 10/15/2018 207,645
Moses Jennifer K. VP of Finance & Admin 10/08/2018 292
Moses Jennifer K. VP of Finance & Admin 10/08/2018 33,390
Strum Jay Chief Scientific Officer 10/04/2018 255
RUDNICK SETH Director 10/04/2018 3,900
RUDNICK SETH Director 10/04/2018 497,210
MURDOCK TERRY L SVP of Development Operations 10/03/2018 47,542
MURDOCK TERRY L SVP of Development Operations 10/03/2018 173,064
Velleca Mark A. President and CEO 09/17/2018 18,600
Velleca Mark A. President and CEO 09/17/2018 331,549
Malik Rajesh Ch. Medical Officer & SVP R&D 09/17/2018 15,746
Malik Rajesh Ch. Medical Officer & SVP R&D 09/17/2018 249,502
Moses Jennifer K. VP of Finance & Admin 09/05/2018 7,733
Moses Jennifer K. VP of Finance & Admin 09/05/2018 44,700
RUDNICK SETH Director 09/04/2018 3,900
RUDNICK SETH Director 09/04/2018 599,483
MURDOCK TERRY L SVP of Development Operations 09/04/2018 47,542
MURDOCK TERRY L SVP of Development Operations 09/04/2018 211,065
Strum Jay Chief Scientific Officer 08/30/2018 299,876
Strum Jay Chief Scientific Officer 08/29/2018 296,095
Malik Rajesh Ch. Medical Officer & SVP R&D 08/15/2018 15,746
Malik Rajesh Ch. Medical Officer & SVP R&D 08/15/2018 211,023
Velleca Mark A. President and CEO 08/15/2018 18,600
Velleca Mark A. President and CEO 08/15/2018 279,378
RUDNICK SETH Director 08/06/2018 3,900
RUDNICK SETH Director 08/06/2018 506,901
Moses Jennifer K. VP of Finance & Admin 08/06/2018 292
Moses Jennifer K. VP of Finance & Admin 08/06/2018 38,093
MURDOCK TERRY L SVP of Development Operations 08/03/2018 47,542
MURDOCK TERRY L SVP of Development Operations 08/03/2018 178,061
Malik Rajesh Ch. Medical Officer & SVP R&D 07/16/2018 15,746
Malik Rajesh Ch. Medical Officer & SVP R&D 07/16/2018 159,248
Velleca Mark A. President and CEO 07/16/2018 18,600
Velleca Mark A. President and CEO 07/16/2018 210,313
Moses Jennifer K. VP of Finance & Admin 07/05/2018 292
Moses Jennifer K. VP of Finance & Admin 07/05/2018 34,245
Malik Rajesh Ch. Medical Officer & SVP R&D 06/15/2018 15,746
Malik Rajesh Ch. Medical Officer & SVP R&D 06/15/2018 167,326
Malik Rajesh Ch. Medical Officer & SVP R&D 06/08/2018 1,638
Moses Jennifer K. VP of Finance & Admin 06/05/2018 292
Moses Jennifer K. VP of Finance & Admin 06/05/2018 29,078
Thorp Clay 10% Owner 05/30/2018 38,400,000
Velleca Mark A. President and CEO 05/31/2018 3,900
Thorp Clay 10% Owner 05/23/2018 25,250
Thorp Clay 10% Owner 05/22/2018 300,016
Thorp Clay 10% Owner 05/21/2018 1,591,411
Velleca Mark A. President and CEO 05/15/2018 27,900
Velleca Mark A. President and CEO 05/15/2018 347,064
Malik Rajesh Ch. Medical Officer & SVP R&D 05/15/2018 15,746
Malik Rajesh Ch. Medical Officer & SVP R&D 05/15/2018 174,821
Moses Jennifer K. VP of Finance & Admin 05/07/2018 292
Moses Jennifer K. VP of Finance & Admin 05/07/2018 33,750
Velleca Mark A. President and CEO 04/16/2018 27,900
Velleca Mark A. President and CEO 04/16/2018 269,971
Malik Rajesh Ch. Medical Officer & SVP R&D 04/16/2018 15,746
Malik Rajesh Ch. Medical Officer & SVP R&D 04/16/2018 136,135
Moses Jennifer K. VP of Finance & Admin 04/05/2018 292
Moses Jennifer K. VP of Finance & Admin 04/05/2018 28,103
Velleca Mark A. President and CEO 03/15/2018 27,900
Velleca Mark A. President and CEO 03/15/2018 286,466
Malik Rajesh Ch. Medical Officer & SVP R&D 03/15/2018 3,348
Malik Rajesh Ch. Medical Officer & SVP R&D 03/15/2018 144,151
Malik Rajesh Ch. Medical Officer & SVP R&D 03/08/2018 1,638
Moses Jennifer K. VP of Finance & Admin 03/05/2018 292
Moses Jennifer K. VP of Finance & Admin 03/05/2018 19,912
Velleca Mark A. President and CEO 02/15/2018 27,900
Velleca Mark A. President and CEO 02/15/2018 150,015
Malik Rajesh Ch. Medical Officer & SVP R&D 02/15/2018 1,213
Malik Rajesh Ch. Medical Officer & SVP R&D 02/15/2018 75,520
Moses Jennifer K. VP of Finance & Admin 02/05/2018 292
Moses Jennifer K. VP of Finance & Admin 02/05/2018 17,242
Velleca Mark A. President and CEO 01/16/2018 27,900
Velleca Mark A. President and CEO 01/16/2018 172,395
Malik Rajesh Ch. Medical Officer & SVP R&D 01/16/2018 1,133
Malik Rajesh Ch. Medical Officer & SVP R&D 01/16/2018 86,693
Moses Jennifer K. VP of Finance & Admin 01/05/2018 292
Moses Jennifer K. VP of Finance & Admin 01/05/2018 14,970
Velleca Mark A. President and CEO 12/18/2017 27,900
Velleca Mark A. President and CEO 12/18/2017 150,106
MedImmune Ventures, Inc. 10% Owner 12/15/2017 3,950,000
MedImmune Ventures, Inc. 10% Owner 05/17/2017 1,125,000
MedImmune Ventures, Inc. 10% Owner 12/01/2017 2,644,644
MedImmune Ventures, Inc. 10% Owner 11/20/2017 4,002,000
ESHELMAN FREDRIC N Director 11/13/2017 4,932,500
Eshelman Ventures, LLC 10% Owner 05/22/2017 4,500,000
Thorp Clay 10% Owner 05/22/2017 1,999,995
ESHELMAN FREDRIC N Director 05/22/2017 4,500,000
MUIR GLENN P Director 05/22/2017 300,000
MedImmune Ventures, Inc. 10% Owner 05/22/2017 1,125,000
RA CAPITAL MANAGEMENT, LLC Fmr 10% Owner See Footnote (2) 05/22/2017 6,000,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
06/30/2021
1.28%
2Q
12/31/2021
03/31/2021
3.05%
3Q
12/31/2021
12/31/2020
10.73%
4Q
12/31/2021
09/30/2020
10.91%
5Q
12/31/2021
06/30/2020
11.19%
6Q
12/31/2021
03/31/2020
11.37%
7Q
12/31/2021
12/31/2019
11.85%
8Q
12/31/2021
09/30/2019
11.94%
9Q
12/31/2021
06/30/2019
12.05%
10Q
12/31/2021
03/31/2019
12.16%
11Q
12/31/2021
09/30/2018
31.04%
13Q
12/31/2021
06/30/2018
34.95%
14Q
12/31/2021
03/31/2018
42.86%
15Q
Load More

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
1.28%
2Q
03/31/2021
3.05%
3Q
12/31/2020
10.73%
4Q
09/30/2020
10.91%
5Q
06/30/2020
11.19%
6Q
03/31/2020
11.37%
7Q
12/31/2019
11.85%
8Q
09/30/2019
11.94%
9Q
06/30/2019
12.05%
10Q
03/31/2019
12.16%
11Q
09/30/2018
31.04%
13Q
06/30/2018
34.95%
14Q
03/31/2018
42.86%
15Q
Load More